SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Neurocrine Biosciences (NBIX)
NBIX 146.52-0.5%10:46 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jim Haynes who wrote (745)5/30/2001 2:52:41 PM
From: scaram(o)uche  Read Replies (2) of 1834
 
Jim and IJ:

Thanks for the kudos. As you are both veteran biotech investors, you don't need this reminder. However, there may be newbies wandering into the thread. So........

INVESTING IN ANY DEVELOPMENTAL-STAGE BIOTECH INVOLVES EXTREME RISK.

Ralf is correct..... there is significant downside risk in NBIX. If you can't put together a **basket** of leveraged stocks like NBIX, then you don't belong in biotech!

The competent biotech investor looks for his BASKET to appreciate, not any particular stock. The really good ones among the competent pick a higher frequency of winners than losers. The best of those among the competent still have losers, and not one of those will be able to tell you with certainty that NBIX isn't going to crash and burn. However, it belongs in my basket.

Cheers! Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext